[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Niacin.]
[L04AA27, fingolimod, The metabolism of Fingolimod can be decreased when combined with Niacin.]
[J01EC02, sulfadiazine, The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Niacin.]
[J01EC01, sulfamethoxazole, The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Niacin.]
[S01AB02, sulfisoxazole, The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Niacin.]
[A10BB04, glibornuride, The therapeutic efficacy of Glibornuride can be decreased when used in combination with Niacin.]
[A10BC01, glymidine, The therapeutic efficacy of Glymidine can be decreased when used in combination with Niacin.]
[N06DA01, tacrine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Niacin.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Niacin.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Niacin.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Niacin.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Niacin.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Niacin.]
[N05AC02, thioridazine, The metabolism of Thioridazine can be decreased when combined with Niacin.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Niacin.]
[B01AC05, ticlopidine, The metabolism of Ticlopidine can be decreased when combined with Niacin.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Niacin.]
[A10BB05, tolazamide, The therapeutic efficacy of Tolazamide can be decreased when used in combination with Niacin.]
[V04CA01, tolbutamide, The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Niacin.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Niacin.]
[N06AX05, trazodone, The metabolism of Trazodone can be decreased when combined with Niacin.]
[S01BA05, triamcinolone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triamcinolone is combined with Niacin.]
[N05CD05, triazolam, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Triazolam.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be decreased when combined with Niacin.]
[J01EA01, trimethoprim, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trimethoprim is combined with Niacin.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Niacin.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be decreased when combined with Niacin.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be decreased when combined with Niacin.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Niacin.]
[A10BH05, linagliptin, The therapeutic efficacy of Linagliptin can be decreased when used in combination with Niacin.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be decreased when combined with Niacin.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Niacin.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Niacin.]
[B01AA03, warfarin, The metabolism of Warfarin can be decreased when combined with Niacin.]
[S01AA13, fusidic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Fusidic acid.]
[J05AF01, zidovudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Niacin.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be decreased when combined with Niacin.]
[J05AE02, indinavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Niacin.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be decreased when combined with Niacin.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Niacin.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be decreased when combined with Niacin.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Niacin.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Ibandronate.]
[N05AE04, ziprasidone, The metabolism of Ziprasidone can be decreased when combined with Niacin.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be decreased when combined with Niacin.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Niacin.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Niacin.]
[C07AB03, atenolol, The metabolism of Atenolol can be decreased when combined with Niacin.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Niacin.]
[M03BX01, baclofen, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Niacin.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Niacin.]
[G04BD12, mirabegron, The metabolism of Mirabegron can be decreased when combined with Niacin.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be decreased when combined with Niacin.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be decreased when combined with Niacin.]
[C08CA13, lercanidipine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lercanidipine is combined with Niacin.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Niacin.]
[G04BD10, darifenacin, The metabolism of Darifenacin can be decreased when combined with Niacin.]
[G04BE03, sildenafil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Niacin.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Niacin.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Niacin.]
[A10BH04, alogliptin, The therapeutic efficacy of Alogliptin can be decreased when used in combination with Niacin.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Niacin.]
[A10BK02, canagliflozin, The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Niacin.]
[A06AX06, tegaserod, The metabolism of Tegaserod can be decreased when combined with Niacin.]
[A10AE05, insulin detemir, The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Niacin.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be decreased when combined with Niacin.]
[A10BX05, pramlintide, The therapeutic efficacy of Pramlintide can be decreased when used in combination with Niacin.]
[M01AH01, celecoxib, The metabolism of Celecoxib can be decreased when combined with Niacin.]
[C10AC04, colesevelam, Colesevelam can cause a decrease in the absorption of Niacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA18, everolimus, The metabolism of Everolimus can be decreased when combined with Niacin.]
[N04AC01, benztropine, The metabolism of Benzatropine can be decreased when combined with Niacin.]
[L01EC02, dabrafenib, The metabolism of Dabrafenib can be decreased when combined with Niacin.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Niacin.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Niacin.]
[C08EA02, bepridil, The metabolism of Bepridil can be decreased when combined with Niacin.]
[A10BJ03, lixisenatide, The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Niacin.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Niacin.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Niacin.]
[A10BK01, dapagliflozin, The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Niacin.]
[C07AB04, acebutolol, The metabolism of Acebutolol can be decreased when combined with Niacin.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Niacin.]
[S03BA03, betamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Niacin.]
[S01ED02, betaxolol, The metabolism of Betaxolol can be decreased when combined with Niacin.]
[C10AB02, bezafibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Bezafibrate.]
[A10BJ04, albiglutide, The therapeutic efficacy of Albiglutide can be decreased when used in combination with Niacin.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be decreased when combined with Niacin.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be decreased when combined with Niacin.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Niacin.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Niacin.]
[A10BK03, empagliflozin, The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Niacin.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be decreased when combined with Niacin.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Niacin.]
[A10BJ05, dulaglutide, The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Niacin.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Niacin.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Niacin.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Niacin.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Niacin.]
[N06AX11, mirtazapine, The metabolism of Mirtazapine can be decreased when combined with Niacin.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Niacin.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be decreased when combined with Niacin.]
[N02BE01, acetaminophen, The metabolism of Acetaminophen can be decreased when combined with Niacin.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Niacin.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be decreased when combined with Niacin.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Niacin.]
[A10BF01, acarbose, The therapeutic efficacy of Acarbose can be decreased when used in combination with Niacin.]
[A10AE06, insulin degludec, The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Niacin.]
[C10AD06, acipimox, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Acipimox.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Niacin.]
[J02AC05, isavuconazole, The metabolism of Isavuconazole can be decreased when combined with Niacin.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be decreased when combined with Niacin.]
[J05AF13, tenofovir alafenamide, The metabolism of Tenofovir alafenamide can be decreased when combined with Niacin.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be decreased when combined with Niacin.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Niacin.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Niacin.]
[A10BB31, acetohexamide, The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Niacin.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be decreased when combined with Niacin.]
[N04BC01, bromocriptine, The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Niacin.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be decreased when combined with Niacin.]
[C03CA02, bumetanide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Bumetanide.]
[N01BB01, bupivacaine, The metabolism of Bupivacaine can be decreased when combined with Niacin.]
[C07AA19, bupranolol, The metabolism of Bupranolol can be decreased when combined with Niacin.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be decreased when combined with Niacin.]
[N05BE01, buspirone, The metabolism of Buspirone can be decreased when combined with Niacin.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Niacin.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Niacin.]
[L01XK03, rucaparib, The metabolism of Rucaparib can be decreased when combined with Niacin.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be decreased when combined with Niacin.]
[L01EF02, ribociclib, The metabolism of Ribociclib can be decreased when combined with Niacin.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Niacin.]
[A10BX06, benfluorex, The therapeutic efficacy of Benfluorex can be decreased when used in combination with Niacin.]
[J05AE09, tipranavir, The metabolism of Tipranavir can be decreased when combined with Niacin.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Niacin.]
[L04AB02, infliximab, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Niacin.]
[L01EX10, midostaurin, The metabolism of Midostaurin can be decreased when combined with Niacin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Niacin.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Niacin.]
[L01EH02, neratinib, The metabolism of Neratinib can be decreased when combined with Niacin.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Niacin.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be decreased when combined with Niacin.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Niacin.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Niacin.]
[J05AX18, letermovir, The metabolism of Letermovir can be decreased when combined with Niacin.]
[A10BJ06, semaglutide, The therapeutic efficacy of Semaglutide can be decreased when used in combination with Niacin.]
[A10BK04, ertugliflozin, The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Niacin.]
[C09AA01, captopril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Captopril.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Niacin.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Niacin.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Niacin.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Niacin.]
[C07AB08, celiprolol, The metabolism of Celiprolol can be decreased when combined with Niacin.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Niacin.]
[L01XX62, ivosidenib, The metabolism of Ivosidenib can be decreased when combined with Niacin.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Niacin.]
[N03AX17, stiripentol, The metabolism of Niacin can be decreased when combined with Stiripentol.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Niacin.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Niacin.]
[A10BB06, carbutamide, The therapeutic efficacy of Carbutamide can be decreased when used in combination with Niacin.]
[R03BB08, revefenacin, The metabolism of Revefenacin can be decreased when combined with Niacin.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be decreased when combined with Niacin.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Niacin.]
[C10AB08, ciprofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Ciprofibrate.]
[P02BX04, triclabendazole, The metabolism of Triclabendazole can be decreased when combined with Niacin.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Niacin.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Niacin.]
[V03AE02, sevelamer, Sevelamer can cause a decrease in the absorption of Niacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be decreased when combined with Niacin.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Niacin.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be decreased when combined with Niacin.]
[N07XX11, pitolisant, The metabolism of Pitolisant can be decreased when combined with Niacin.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be decreased when combined with Niacin.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be decreased when combined with Niacin.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Niacin.]
[G04BE04, yohimbine, The metabolism of Yohimbine can be decreased when combined with Niacin.]
[A10AE03, insulin, regular, pork, The therapeutic efficacy of Insulin pork can be decreased when used in combination with Niacin.]
[J01XX09, daptomycin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Niacin.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be decreased when combined with Niacin.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Niacin.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Niacin.]
[N03AX25, cenobamate, The metabolism of Cenobamate can be decreased when combined with Niacin.]
[R06AB02, dexchlorpheniramine, The metabolism of Dexchlorpheniramine can be decreased when combined with Niacin.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Niacin.]
[J05AE05, amprenavir, The metabolism of Amprenavir can be decreased when combined with Niacin.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Niacin.]
[N02AA08, dihydrocodeine, The metabolism of Dihydrocodeine can be decreased when combined with Niacin.]
[N02CC06, eletriptan, The metabolism of Eletriptan can be decreased when combined with Niacin.]
[C08CA16, clevidipine, The metabolism of Clevidipine can be decreased when combined with Niacin.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Niacin.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Niacin.]
[N02AX07, oliceridine, The metabolism of Oliceridine can be decreased when combined with Niacin.]
[P01BA01, chloroquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Niacin.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be decreased when combined with Niacin.]
[N05AA01, chlorpromazine, The metabolism of Chlorpromazine can be decreased when combined with Niacin.]
[A10BB02, chlorpropamide, The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Niacin.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be decreased when combined with Niacin.]
[C10AC01, cholestyramine resin, Cholestyramine can cause a decrease in the absorption of Niacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M02AA06, etofenamate, The therapeutic efficacy of Etofenamate can be increased when used in combination with Niacin.]
[C10AB09, etofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Etofibrate.]
[N03AX10, felbamate, The metabolism of Felbamate can be decreased when combined with Niacin.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Niacin.]
[A10AF01, insulin, regular, human, The therapeutic efficacy of Insulin human can be decreased when used in combination with Niacin.]
[A02BA01, cimetidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cimetidine is combined with Niacin.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Niacin.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Niacin.]
[S03AA07, ciprofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Niacin.]
[N06AB04, citalopram, The metabolism of Citalopram can be decreased when combined with Niacin.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Niacin.]
[A10BB12, glimepiride, The therapeutic efficacy of Glimepiride can be decreased when used in combination with Niacin.]
[A10BB08, gliquidone, The therapeutic efficacy of Gliquidone can be decreased when used in combination with Niacin.]
[C10AB01, clofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Clofibrate.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Niacin.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Niacin.]
[A10BX16, tirzepatide, The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Niacin.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Niacin.]
[N05AH02, clozapine, The metabolism of Clozapine can be decreased when combined with Niacin.]
[A10BX01, guar gum, The therapeutic efficacy of Guar gum can be decreased when used in combination with Niacin.]
[A10BK06, sotagliflozin, The therapeutic efficacy of Sotagliflozin can be decreased when used in combination with Niacin.]
[R05DA04, codeine, The metabolism of Codeine can be decreased when combined with Niacin.]
[M04AC01, colchicine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Colchicine.]
[C10AC02, colestipol, Colestipol can cause a decrease in the absorption of Niacin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA13, leflunomide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Leflunomide.]
[A10BX03, nateglinide, The therapeutic efficacy of Nateglinide can be decreased when used in combination with Niacin.]
[H01AC03, mecasermin, The therapeutic efficacy of Mecasermin can be decreased when used in combination with Niacin.]
[A10AE04, insulin glargine, The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Niacin.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Niacin.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Niacin.]
[L01EA01, imatinib, The metabolism of Imatinib can be decreased when combined with Niacin.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Nafarelin.]
[N07BC04, lofexidine, The metabolism of Lofexidine can be decreased when combined with Niacin.]
[A03AA04, mebeverine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Mebeverine.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Niacin.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Niacin.]
[A10BF02, miglitol, The therapeutic efficacy of Miglitol can be decreased when used in combination with Niacin.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Niacin.]
[N06AX07, minaprine, The metabolism of Minaprine can be decreased when combined with Niacin.]
[S01XA18, cyclosporine, The metabolism of Cyclosporine can be decreased when combined with Niacin.]
[N06AG02, moclobemide, The metabolism of Moclobemide can be decreased when combined with Niacin.]
[C10AA07, rosuvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Niacin is combined with Rosuvastatin.]
[C03XA02, conivaptan, The metabolism of Conivaptan can be decreased when combined with Niacin.]
[L01BC01, cytarabine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Cytarabine.]
[M03CA01, dantrolene, The therapeutic efficacy of Dantrolene can be increased when used in combination with Niacin.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Niacin.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Niacin.]
[N06AX06, nefazodone, The metabolism of Nefazodone can be decreased when combined with Niacin.]
[N06AB10, escitalopram, The metabolism of Escitalopram can be decreased when combined with Niacin.]
[G04BD08, solifenacin, The metabolism of Solifenacin can be decreased when combined with Niacin.]
[N06AA01, desipramine, The metabolism of Desipramine can be decreased when combined with Niacin.]
[S03BA01, dexamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Dexamethasone.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Niacin.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Niacin.]
[N06BA02, dextroamphetamine, The metabolism of Amphetamine can be decreased when combined with Niacin.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Niacin.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be decreased when combined with Niacin.]
[A10BG03, pioglitazone, The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Niacin.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Niacin.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Niacin.]
[C01AA04, digitoxin, The metabolism of Digitoxin can be decreased when combined with Niacin.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be decreased when combined with Niacin.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be decreased when combined with Niacin.]
[J05AE08, atazanavir, The metabolism of Atazanavir can be decreased when combined with Niacin.]
[C08DB01, diltiazem, The metabolism of Diltiazem can be decreased when combined with Niacin.]
[R06AA02, diphenhydramine, The metabolism of Diphenhydramine can be decreased when combined with Niacin.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Niacin.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Niacin.]
[N05AL04, remoxipride, The metabolism of Remoxipride can be decreased when combined with Niacin.]
[C01BA03, disopyramide, The therapeutic efficacy of Disopyramide can be decreased when used in combination with Niacin.]
[N05AX08, risperidone, The metabolism of Risperidone can be decreased when combined with Niacin.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Niacin.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be decreased when combined with Niacin.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Niacin.]
[C01EB18, ranolazine, The metabolism of Ranolazine can be decreased when combined with Niacin.]
[R03AC12, salmeterol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Salmeterol.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Niacin.]
[N06AA16, dothiepin, The metabolism of Dosulepin can be decreased when combined with Niacin.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Niacin.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be decreased when combined with Niacin.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Niacin.]
[N01AB08, sevoflurane, The metabolism of Sevoflurane can be decreased when combined with Niacin.]
[C10AA01, simvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Niacin is combined with Simvastatin.]
[C07AB13, talinolol, The metabolism of Talinolol can be decreased when combined with Niacin.]
[D01BA02, terbinafine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Terbinafine.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Niacin.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Emetine.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Niacin.]
[C09AA02, enalapril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Niacin.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Niacin.]
[N01AB04, enflurane, The metabolism of Enflurane can be decreased when combined with Niacin.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Niacin.]
[S01GX10, epinastine, The metabolism of Epinastine can be decreased when combined with Niacin.]
[N06AX16, venlafaxine, The metabolism of Venlafaxine can be decreased when combined with Niacin.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Niacin.]
[A10AB06, insulin glulisine, human, The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Niacin.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Iloprost.]
[N02CA02, ergotamine, The metabolism of Ergotamine can be decreased when combined with Niacin.]
[C10AA04, fluvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Niacin is combined with Fluvastatin.]
[N03AD01, ethosuximide, The metabolism of Ethosuximide can be decreased when combined with Niacin.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be increased when used in combination with Niacin.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be decreased when combined with Niacin.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Niacin.]
[N05AE03, sertindole, The metabolism of Sertindole can be decreased when combined with Niacin.]
[L04AD02, tacrolimus, The metabolism of Tacrolimus can be decreased when combined with Niacin.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Niacin.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Niacin.]
[R06AX12, terfenadine, The metabolism of Terfenadine can be decreased when combined with Niacin.]
[N06AB08, fluvoxamine, The metabolism of Fluvoxamine can be decreased when combined with Niacin.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Niacin.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Niacin.]
[C10AA03, pravastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Niacin is combined with Pravastatin.]
[P02CA03, albendazole, The metabolism of Albendazole can be decreased when combined with Niacin.]
[N03AX26, fenfluramine, The metabolism of Fenfluramine can be decreased when combined with Niacin.]
[L04AA40, cladribine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Niacin.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be decreased when combined with Niacin.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Niacin.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Niacin.]
[V03AZ01, ethanol, The risk or severity of adverse effects can be increased when Ethanol is combined with Niacin.]
[N06AB03, fluoxetine, The metabolism of Fluoxetine can be decreased when combined with Niacin.]
[C03CA01, furosemide, The therapeutic efficacy of Furosemide can be increased when used in combination with Niacin.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Alendronic acid.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Niacin.]
[S01AD09, ganciclovir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Ganciclovir.]
[C10AB04, gemfibrozil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Gemfibrozil.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Niacin.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be decreased when combined with Niacin.]
[A10BJ02, liraglutide, The therapeutic efficacy of Liraglutide can be decreased when used in combination with Niacin.]
[A10BB01, glyburide, The therapeutic efficacy of Glyburide can be decreased when used in combination with Niacin.]
[A10BB09, gliclazide, The therapeutic efficacy of Gliclazide can be decreased when used in combination with Niacin.]
[A10BB07, glipizide, The therapeutic efficacy of Glipizide can be decreased when used in combination with Niacin.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Niacin.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Niacin.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Niacin.]
[C07AB09, esmolol, The metabolism of Esmolol can be decreased when combined with Niacin.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Niacin.]
[N01AB01, halothane, The metabolism of Halothane can be decreased when combined with Niacin.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be decreased when combined with Niacin.]
[A10AD05, insulin aspart, human, The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Niacin.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Niacin.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be increased when used in combination with Niacin.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Niacin.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Niacin.]
[C08CA10, nilvadipine, The metabolism of Nilvadipine can be decreased when combined with Niacin.]
[R05DA03, hydrocodone, The metabolism of Hydrocodone can be decreased when combined with Niacin.]
[P01BA02, hydroxychloroquine, The metabolism of Hydroxychloroquine can be decreased when combined with Niacin.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Risedronic acid.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Niacin.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Niacin.]
[N06AA02, imipramine, The metabolism of Imipramine can be decreased when combined with Niacin.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Niacin.]
[A10BH01, sitagliptin, The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Niacin.]
[A10BH02, vildagliptin, The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Niacin.]
[C10AA06, cerivastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Niacin is combined with Cerivastatin.]
[C07AA01, alprenolol, The metabolism of Alprenolol can be decreased when combined with Niacin.]
[V03AB01, ipecac, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Ipecac.]
[J05AF04, stavudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Stavudine.]
[N01AB06, isoflurane, The metabolism of Isoflurane can be decreased when combined with Niacin.]
[J04AC01, isoniazid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Isoniazid.]
[A10BJ01, exenatide, The therapeutic efficacy of Exenatide can be decreased when used in combination with Niacin.]
[C01DA14, isosorbide mononitrate, Niacin may increase the vasodilatory activities of Isosorbide mononitrate.]
[D10BA01, isotretinoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Isotretinoin.]
[P02CF01, ivermectin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Niacin.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Niacin.]
[N05AH03, olanzapine, The metabolism of Olanzapine can be decreased when combined with Niacin.]
[N04BC09, rotigotine, The metabolism of Rotigotine can be decreased when combined with Niacin.]
[C07AG01, labetalol, The metabolism of Labetalol can be decreased when combined with Niacin.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Niacin.]
[S02DA01, lidocaine, The metabolism of Lidocaine can be decreased when combined with Niacin.]
[N02CA07, lisuride, The metabolism of Lisuride can be decreased when combined with Niacin.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Niacin.]
[L01EA03, nilotinib, The metabolism of Nilotinib can be decreased when combined with Niacin.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be decreased when combined with Niacin.]
[M02AA18, meclofenamic acid, The therapeutic efficacy of Meclofenamic acid can be increased when used in combination with Niacin.]
[P01BC02, mefloquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Niacin.]
[N02AB02, meperidine, The metabolism of Meperidine can be decreased when combined with Niacin.]
[N03AB04, mephenytoin, The therapeutic efficacy of Mephenytoin can be increased when used in combination with Niacin.]
[N05AC03, mesoridazine, The metabolism of Mesoridazine can be decreased when combined with Niacin.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be decreased when combined with Niacin.]
[A10BA02, metformin, The therapeutic efficacy of Metformin can be decreased when used in combination with Niacin.]
[A04AA04, dolasetron, The metabolism of Dolasetron can be decreased when combined with Niacin.]
[N07BC02, methadone, The metabolism of Methadone can be decreased when combined with Niacin.]
[N06BA03, methamphetamine, The metabolism of Metamfetamine can be decreased when combined with Niacin.]
[J05AF05, lamivudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Lamivudine.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Niacin.]
[N05AA02, methotrimeprazine, The metabolism of Methotrimeprazine can be decreased when combined with Niacin.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Niacin.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Methyldopa.]
[V04CG05, methylene blue, The metabolism of Methylene blue can be decreased when combined with Niacin.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Niacin.]
[N02CA04, methysergide, The metabolism of Methysergide can be decreased when combined with Niacin.]
[A03FA01, metoclopramide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Metoclopramide.]
[C07AB02, metoprolol, The metabolism of Metoprolol can be decreased when combined with Niacin.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be decreased when combined with Niacin.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Niacin.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Niacin.]
[G03XB01, mifepristone, The therapeutic efficacy of Mifepristone can be decreased when used in combination with Niacin.]
[J01AA08, minocycline, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Minocycline.]
[N06BA12, lisdexamfetamine, The metabolism of Lisdexamfetamine can be decreased when combined with Niacin.]
[C01BD01, amiodarone, The metabolism of Amiodarone can be decreased when combined with Niacin.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Niacin.]
[A04AA05, palonosetron, The metabolism of Palonosetron can be decreased when combined with Niacin.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Niacin.]
[J05AJ01, raltegravir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Raltegravir.]
[N06AA17, amoxapine, The metabolism of Amoxapine can be decreased when combined with Niacin.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Niacin.]
[C07AA12, nadolol, The metabolism of Nadolol can be decreased when combined with Niacin.]
[N07BB04, naltrexone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Naltrexone.]
[N06BA01, amphetamine, The metabolism of Amphetamine can be decreased when combined with Niacin.]
[A10BG01, troglitazone, The therapeutic efficacy of Troglitazone can be decreased when used in combination with Niacin.]
[N06AX21, duloxetine, The metabolism of Duloxetine can be decreased when combined with Niacin.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Niacin.]
[L02BG04, letrozole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Letrozole.]
[A10BX02, repaglinide, The therapeutic efficacy of Repaglinide can be decreased when used in combination with Niacin.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Niacin.]
[J02AA01, amphotericin B, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Amphotericin B.]
[C04AE02, nicergoline, The metabolism of Nicergoline can be decreased when combined with Niacin.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Niacin.]
[J01XE01, nitrofurantoin, The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Niacin.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Niacin.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Norfloxacin.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Niacin.]
[S02AA16, ofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Ofloxacin.]
[N02AA02, opium, The metabolism of Opium can be decreased when combined with Niacin.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Niacin.]
[C07AA02, oxprenolol, The metabolism of Oxprenolol can be decreased when combined with Niacin.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be decreased when combined with Niacin.]
[N02AA11, oxymorphone, The metabolism of Oxymorphone can be decreased when combined with Niacin.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be decreased when combined with Niacin.]
[C07AA23, penbutolol, The metabolism of Penbutolol can be decreased when combined with Niacin.]
[M01CC01, penicillamine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Penicillamine.]
[C08EX02, perhexiline, The metabolism of Perhexiline can be decreased when combined with Niacin.]
[N05AB03, perphenazine, The metabolism of Perphenazine can be decreased when combined with Niacin.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Niacin.]
[A10BA01, phenformin, The therapeutic efficacy of Phenformin can be decreased when used in combination with Niacin.]
[N03AA02, phenobarbital, The metabolism of Phenobarbital can be decreased when combined with Niacin.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Niacin.]
[N03AB02, phenytoin, The therapeutic efficacy of Phenytoin can be increased when used in combination with Niacin.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Niacin.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Niacin.]
[C07AA03, pindolol, The metabolism of Pindolol can be decreased when combined with Niacin.]
[C10AA05, atorvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Niacin is combined with Atorvastatin.]
[J05AE01, saquinavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Niacin.]
[N05AC04, pipothiazine, The metabolism of Pipotiazine can be decreased when combined with Niacin.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Eprosartan.]
[J05AG02, delavirdine, The metabolism of Delavirdine can be decreased when combined with Niacin.]
[A10BG02, rosiglitazone, The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Niacin.]
[J05AE03, ritonavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ritonavir is combined with Niacin.]
[A10BH03, saxagliptin, The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Niacin.]
[A10AD04, insulin lispro, The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Niacin.]
[C10AA08, pitavastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Niacin is combined with Pitavastatin.]
[C07AB01, practolol, The metabolism of Practolol can be decreased when combined with Niacin.]
[N03AA03, primidone, The metabolism of Primidone can be decreased when combined with Niacin.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Niacin.]
[L01XB01, procarbazine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Procarbazine.]
[C10AB05, fenofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Fenofibrate.]
[N05AB04, prochlorperazine, The metabolism of Prochlorperazine can be decreased when combined with Niacin.]
[G03DA04, progesterone, The metabolism of Progesterone can be decreased when combined with Niacin.]
[N05AA03, promazine, The metabolism of Promazine can be decreased when combined with Niacin.]
[R06AD02, promethazine, The metabolism of Promethazine can be decreased when combined with Niacin.]
[C01BC03, propafenone, The metabolism of Propafenone can be decreased when combined with Niacin.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Niacin.]
[N01AX10, propofol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Propofol.]
[N02AC04, propoxyphene, The metabolism of Dextropropoxyphene can be decreased when combined with Niacin.]
[C07AA05, propranolol, The metabolism of Propranolol can be decreased when combined with Niacin.]
[H03BA02, propylthiouracil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propylthiouracil is combined with Niacin.]
[R03DC03, montelukast, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Niacin.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Niacin.]
[C01BA01, quinidine, The metabolism of Quinidine can be decreased when combined with Niacin.]
[P01BC01, quinine, The therapeutic efficacy of Quinine can be decreased when used in combination with Niacin.]
[A02BA02, ranitidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Ranitidine.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Niacin.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Niacin.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Niacin.]
